Cargando…
Methotrexate myelopathy after intrathecal chemotherapy: a case report
INTRODUCTION: Methotrexate is often administered intrathecally or into the cerebral ventricles, particularly in patients with central nervous system tumors. However, in addition to chemical arachnoiditis, methotrexate can induce severe myelopathy. CASE PRESENTATION: A 59-year-old Japanese man with d...
Autores principales: | Murata, Ken-ya, Maeba, Ayaka, Yamanegi, Mika, Nakanishi, Ichiro, Ito, Hidefumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470338/ https://www.ncbi.nlm.nih.gov/pubmed/26055509 http://dx.doi.org/10.1186/s13256-015-0597-5 |
Ejemplares similares
-
Radiation Myelopathy Caused by Palliative Radiotherapy and Intrathecal Methotrexate
por: Fukuda, Yukiko, et al.
Publicado: (2022) -
Subacute quadriplegic myelopathy following intrathecal methotrexate
por: Maramattom, Boby Varkey, et al.
Publicado: (2016) -
Anti-U3 ribonucleoprotein antibody-positive inflammatory myopathy: a case report
por: Murata, Ken-ya, et al.
Publicado: (2016) -
Intrathecal Methotrexate-Induced Necrotizing Myelopathy: A Case
Report and Review of Histologic Features
por: Tariq, Hamza, et al.
Publicado: (2018) -
Intrathecal methotrexate in combination with systemic chemotherapy in glioblastoma patients with leptomeningeal dissemination: A retrospective analysis
por: Kang, Xun, et al.
Publicado: (2022)